Omaveloxolone

Summary

To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the reasons for the difference in availability of Omaveloxolone (Skyclarys) as a treatment for Friedrich's ataxia in (a) Scotland and (b) England a

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 3 November 2025

   Written question

   To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the reasons for the difference in availability of Omaveloxolone (Skyclarys) as a treatment for Friedrich's ataxia in (a) Scotland and (b) England a

   Source: Commons

2. 11 November 2025

   Answer

   The Department has made no assessment of the reasons for the difference in the availability of omaveloxolone (Skyclarys) as a treatment for Friedrich's ataxia in Scotland, England, and Wales.Decisions on the availability of medicines are taken by the resp...

   Source: Written answer

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

• · Department of Health and Social Care · Answering body

Related records

No cross-record relationships stored yet.